These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33148261)

  • 1. Development and psychometric evaluation of the assessment of self-injection questionnaire: an adaptation of the self-injection assessment questionnaire.
    Pompilus F; Ciesluk A; Strzok S; Ciaravino V; Harris K; Szegvari B; Mountian I; Cleanthous S; Meunier J
    Health Qual Life Outcomes; 2020 Nov; 18(1):355. PubMed ID: 33148261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ).
    Keininger D; Coteur G
    Health Qual Life Outcomes; 2011 Jan; 9():2. PubMed ID: 21232106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol.
    Pouls BPH; Kristensen LE; Petersson M; van den Bemt BJF; Ballerini L; Bruggraber R; Karlen H; Mountian I; van Bracht E; Wiegratz S; Jørgensen TS
    Expert Opin Drug Deliv; 2020 May; 17(5):705-711. PubMed ID: 32154740
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura.
    Oladapo A; Ito D; Rodriguez AM; Philpott S; Krupnick R; Allen V; Hibbard C; Scully M; Ewenstein B
    J Patient Rep Outcomes; 2023 Jul; 7(1):68. PubMed ID: 37450201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients.
    Abetz L; Rajagopalan K; Mertzanis P; Begley C; Barnes R; Chalmers R;
    Health Qual Life Outcomes; 2011 Dec; 9():111. PubMed ID: 22152125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) - clinical trial and the SAPS - real world patient-reported outcomes.
    Armstrong AW; Banderas B; Foley C; Stokes J; Sundaram M; Shields AL
    J Dermatolog Treat; 2017 Sep; 28(6):505-514. PubMed ID: 28147886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).
    Matza LS; Boye KS; Stewart KD; Paczkowski R; Jordan J; Murray LT
    J Patient Rep Outcomes; 2018 Dec; 2():43. PubMed ID: 30294713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form.
    Tolstrup LK; Pappot H; Zangger G; Bastholt L; Zwisler AD; Dieperink KB
    Health Qual Life Outcomes; 2018 Apr; 16(1):77. PubMed ID: 29703191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
    Lipton RB; Gandhi P; Stokes J; Cala ML; Evans CJ; Knoble N; Gelhorn HL; Revicki D; Viswanathan HN; Dodick DW
    Headache; 2022 Jan; 62(1):89-105. PubMed ID: 34962305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
    Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
    J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia - development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES).
    Sommer R; Blömeke J; Dabs M; Witt S; Bullinger M; Quitmann J
    Disabil Rehabil; 2017 Dec; 39(24):2499-2503. PubMed ID: 27636099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
    Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
    Patient; 2013; 6(4):291-305. PubMed ID: 24062234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection.
    Tatlock S; Grant L; Spertus JA; Khan I; Arbuckle R; Manvelian G; Sanchez RJ
    Value Health; 2015 Dec; 18(8):1000-7. PubMed ID: 26686784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the Multiple Myeloma Symptom and Impact Questionnaire: A New Patient-Reported Outcome Instrument to Assess Symptom and Impacts in Patients With Multiple Myeloma.
    Gries KS; Fastenau J; Seo C; Potrata B; Iaconangelo C; Serrano D
    Value Health; 2021 Dec; 24(12):1807-1819. PubMed ID: 34838279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.